Key Takeaways
- Volume growth absorbed price deflation: HPPC volumes rose 7-8% QoQ, but falling raw material and finished goods prices masked that growth in reported revenue.
- Subsidiary integration is delivering: Unitop and Tristar together grew H1 top line ~40-45% versus pre-acquisition, driven by cross-selling and in-house sourcing shifts that are already visible in consolidated numbers.
- Margins held steady in a tough quarter: Gross margin improved 357 bps in H1, and H1 EBITDA of ₹114 crore is the highest ever consolidated, achieved by passing through price hikes while holding absolute margin.
- H2 outlook is cautious, not bearish: Management flagged Western recession risk and declined to give firm guidance, but said it would be happy with H1 replication plus 5-10% growth.
- What to watch next quarter: Whether raw material price stability actually materializes, the pace of new product commercialisation (silicon polymers, pharma coatings, polyester sizing), and any demand recovery in Europe-exposed Tristar.
Volume vs Price: The Quarter's Real Story
- HPPC volume up, revenue muted: Consolidated HPPC volumes grew nearly 7-8% QoQ, but raw material prices fell, so finished goods prices also fell, compressing the revenue line.
- Standalone tells the same tale: Standalone revenue rose QoQ from ₹233.7 cr to ₹240.9 cr despite falling FG prices; volumes grew across all three segments.
- Textile exports hit by cotton chaos: Cotton prices swung from above ₹1 lakh to ₹60,000-70,000, so spinning mills stopped producing yarn, which cascaded into lower fabric processing; European markets were very slow.
- YoY comparisons are misleading: Q2 last year was abnormal: the pipeline was empty after COVID/supply chain issues in Q1, so Rossari supplied at acquisition contract prices with higher volumes to big customers.
Chari: "The supply chain has stabilized, but the prices have not stabilized yet. There is still huge volatility in the prices."
Subsidiary Integration & Synergy Delivery
- H1 growth accelerated sharply: Unitop and Tristar combined grew top line ~40-45% in H1 versus the pre-acquisition period, with substantial volume increases driven by Rossari's marketing and distribution efforts.
- Cross-purchasing unlocked: Rossari started buying a substantial amount of surfactants from Unitop that it was not purchasing earlier, shifting raw material sourcing in-house.
- Cross-selling is working: Rossari's customer connections drove business into subsidiaries; Rossari positioned as a non-agro single-point supplier; combined R&D, production, and consultant teams worked as one on four projects, catalysing growth beyond the subsidiaries' historical 10-20% average.
- Unitop is the standout: Management called Unitop "outstanding" on profitability, volume, and value growth; leaders in agro surfactants with very good production facilities and market demand; no governance issues.
- Tristar faces Europe headwinds: Tristar grew well last quarter but major exports go to Europe, where demand for personal care additives is subdued; slowdown in European and US markets observed.
- Stake increased: Rossari acquired an additional 15% in Unitop and 8% in Tristar during the quarter, taking holdings to 80% and 84% respectively, funded through internal accruals and liquidation of investments.
- Subsidiary quarterly disclosure declined: Management refused to disclose Tristar and Unitop quarterly revenues, stating disclosure happens only on annualised accounts.
Chari: "...all the acquisitions have done exceedingly well. We have been able to integrate very well, we have had no surprises in all the acquisitions. Unitop of course, is outstanding. The amount of growth which has happened both on profitability and on volume and value growth we are happy."
New Product Pipeline & R&D Commercialisation
- Textile chemicals advancing: Polyester resin sizing for water jet looms has taken off; acrylic-based sizes for polyester approved by a large manufacturer with first orders dispatched; novel coating polymers for technical textiles successfully trialled and first bulk orders received.
- Silicon polymers indigenised: Imported silicon polymers used in textile finishing successfully substituted; block silicone technology manufactured at Romakk and expanded Dahej facility; breakthrough in silicon polymer for agro (super spreading and wetting) with first batches made and approved at a few large users.
- Pharma coatings ready: Special polymers for pharma coating developed; manufacturing approval at Dahej received; manufacturing to commence shortly.
- Animal Health expansion: Granulation facility recently commissioned to introduce a range of new products; planning to put resources into vitamin pre-mix, a very large portion of the business.
- Green surfactants pipeline: R&D work started on glycolipids; will help enter personal care ingredients and formulations for animal health, home care, laundry detergents, and pet care shampoos.
- Grinding aids reintroduction: In process of reintroducing grinding aids and dispersants for ceramic and cement industries.
- Cross-entity product development: Joint development between Unitop and Rossari led to first orders for additives in the regenerated cellular market; spin finishes for primary and secondary finishes introduced successfully in polyester POY, FDY, and polypropylene.
- SAP HANA implementation underway: ERP implementation in process across all group companies to integrate software, improve data veracity, and enable more informed decisions on products, margins, and strategy.
Margin Resilience & Cost Structure
- Gross margin improved: Gross margins during H1 improved by 357 bps; EBITDA margins stable at 13.3%, in line with last year.
- H1 EBITDA a record: ₹114 crore H1 EBITDA is the highest ever consolidated; management credited bravery in passing on price hikes to customers while maintaining absolute margin rather than percentage margin.
- The pass-through strategy: When raw material prices increased substantially, Rossari did not increase the amount of margin but maintained margins, leading to gradual improvement.
- Inventory conservatism: Inventory reduced from ₹120 crore to ₹111 crore QoQ; management conscious of not taking long positions in any raw material and will remain conservative this quarter.
- Depreciation drag: Higher depreciation (₹15.6 cr) due to amortisation of fair valuation on consolidation from purchase price allocation.
- Interest cost split: Higher interest cost (₹8.2 cr) partly from increased borrowing, but ~65-70% is a notional, non-cash IND AS accounting charge for purchase price allocation of subsidiaries that will continue until 100% acquisition is done.
Chari: "We have been brave, we have been able to pass on price hikes to the customers. ... when the price increased substantially, we did not increase the amount of margin, but we maintained our margins. And so that is why we are seeing a gradual improvement in margins across Rossari."
Demand Environment & End-Market Health
- Textile exports under pressure: Exports suffered for all players; per-kilo prices came down; cotton price volatility disrupted spinning, fabric production, and processing; European markets very slow.
- Europe slowdown hitting Tristar: Subdued demand from Europe for personal care additives; slowdown in European markets observed.
- Agro surfactants resilient: Unitop's agro surfactants business showed outstanding growth; market demand very good.
- Raw material price stability not yet here: After sharp volatility, supply chain has stabilized but prices have not stabilized yet; some price stability is now coming into the market, helping maintain the margin profile.
- Export opportunities flagged: Phenoxy propanol (cross-synergy between Rossari, Unitop, Tristar) could drive good volume growth; agro surfactants and surfactants as a category could see substantial uptick if export markets improve; silicones for agro application could have a very good market in future.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| H2 FY23 top line | Replicate H1 with 5-10% growth | H2 FY23 |
| FY23 full-year revenue | ₹1,800 crore to ₹2,000 crore | FY23 |
| FY23 EBITDA margin | 12% to 14% range | FY23 |
| Gross margin recovery | Return to 30-35% consolidated | 2-3 years |
| Gross margin near-term | Stay at current 26-27% | Next few quarters |
| EBITDA margin objective | Return to 14-15% | Normalised operating environment (no date) |
| EBITDA margin longer-term | Return to ~15% | Longer period (no date) |
| Working capital cycle | 70-75 days consolidated | Internal target (no date) |
| IND AS interest charge | Continue as notional, non-cash charge | Until 100% subsidiary acquisition completed |
| Inventory posture | Remain conservative, no long positions | This quarter |
| Silicon polymers for agro | Approvals to culminate in business | Next year |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Consolidated revenue | ₹425.4 cr, down 2% QoQ from ₹434.7 cr |
| Standalone revenue | ₹240.9 cr, up 3% QoQ from ₹233.7 cr |
| HPPC revenue | ₹303.9 cr, 71% of total revenue |
| TSC revenue | ₹91.4 cr, 22% of total revenue |
| AHN revenue | ₹30.2 cr, 7% of total revenue |
| Consolidated EBITDA | ₹56.6 cr, down 2% QoQ from ₹57.7 cr |
| Consolidated PAT | ₹23.9 cr, down 17% QoQ from ₹28.7 cr |
| H1 FY23 EBITDA margin | 13.3%, stable YoY |
| H1 FY23 gross margin improvement | 357 bps YoY |
| HPPC volume growth | 7%-8% QoQ, consolidated |
| Unitop and Tristar combined H1 top-line growth | 40%-45%, vs pre-acquisition H1 |
| Unitop and Tristar combined YoY top-line growth | 60%-70%, post one year of acquisition |
| Capacity utilization | 50%-55%, across all entities, similar to Q1 |
| FY23 top-line outlook | ₹1,800 cr to ₹2,000 cr |
| FY23 EBITDA margin outlook | 12% to 14% |